Main Menu

Science Talk

With our Science Talk blog, we hope to lift the lid on the black box that is the ICR: to show you inside our labs, to introduce you to a few of the people here who make the discoveries, and to allow them to tell some of the stories behind the science. We try to put our discoveries in a wider scientific context, and give an idea of how our science is actually done. We also give you the view from the ICR of important developments in the wider world of cancer research.

“Becoming a cancer patient has given me extra perspective” – Paul’s story

“Becoming a cancer patient has given me extra perspective” – Paul’s story

Professor Paul Workman is Harrap Professor of Pharmacology and Therapeutics at The Institute of Cancer Research. He has worked in the field of cancer research for more than 50 years and was the ICR’s Chief Executive and President from 2014 to 2021. During his leadership, he oversaw many of our scientific successes – including the development of smarter and kinder forms of radiotherapy. Now, after being diagnosed with prostate cancer himself in 2022, he reflects on his experience as both a leading cancer scientist and now a cancer patient.

Find out more

From cancer diagnosis to London Marathon mission – Harry’s story

From cancer diagnosis to London Marathon mission – Harry’s story

As a fit and healthy former firefighter, Harry Hall didn’t think there was anything to worry about when he developed a lump in his neck. But after his wife persuaded him to go to the doctors, tests diagnosed Harry with tongue cancer. Here, Harry explains why he wants to raise funds to support our vital research by running the London Marathon.

Find out more

Breaking down regulatory barriers could deliver step change improvements to prostate cancer outcomes

Breaking down regulatory barriers could deliver step change improvements to prostate cancer outcomes

We have seen major advances in prostate cancer research, and people with the disease are living longer than ever. However, more needs to be done to harness scientific discoveries and bring innovative drugs to patients. Here we discuss the regulatory landscape and reforms needed to ensure patients can access the most innovative treatments as quickly as possible.

Find out more